Clinical Trial Update: A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating belimumab's effect on vaccine responses in systemic lupus erythematosus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED | Results posted: 2016-07-25